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Abstract Squamous cell carcinoma (SCC) of the larynx is
extremely rare in adolescents and typically has an aggres-
sive nature. The mechanism of laryngeal oncogenesis is
complex and little is known about the role that human
papillomavirus (HPV) plays in SCC in adolescents. We
report a case of invasive laryngeal SCC that co-expressed
HPV DNA subtypes 16 and 18 in a 13 year-old boy.
Detection of HPV DNA types 6, 11, 16, 18, 31, 33, and 51
was performed by in situ hybridization, with conﬁrmation
by polymerase chain reaction. Immunohistochemical
staining with p16 and HPV 16/18 revealed diffusely posi-
tive staining in the tumor cells. Coinfection by HPV DNA
types 16 and 18 has not been previously reported, but our
case suggests that HPV is a risk factor in developing lar-
yngeal SCC in children and adolescents. Future studies
evaluating HPV in the pathogenesis of these lesions is
recommended to determine its prognostic signiﬁcance.
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Introduction
Squamous cell carcinoma (SCC) of the larynx is more
common in adults than adolescents and is essentially a
lifestyle-related cancer occurring after decades of tobacco
use. The literature contains fewer than 75 cases of SCC in
the pediatric population to date, therefore, the treatment
and prognosis of laryngeal SCC is not well-deﬁned.
Recently, studies have suggested that prognosis may be
affected by the presence of chromosomal translocation
(15;19) or of human papillomavirus (HPV) DNA [1–8]. In
this case report, we present a 13 year-old boy with invasive
SCC in his right vocal cord. Immunohistochemistry, in situ
hybridization (ISH) and polymerase chain reaction (PCR)
were performed to identify possible expression of p16 and
infection with HPV DNA. Dual-color ﬂuorescence in situ
hybridization (FISH) assays were utilized to detect trans-
location (15;19).
Report of a Case
A 13 year-old boy presented to an otolaryngologist for
evaluation of prolonged hoarseness, which was unassoci-
ated with dysphasia or odynophagia. He and his mother
reported the presence of symptoms for approximately
1 year, buthad givenno serious thoughttotheir origingiven
his pubertal age and participation in strenuous vocal activ-
ities as a school mascot. He reported no previous history of
laryngeal papillomatosis, laryngeal surgery, trauma, intu-
bation, radiation, alcohol or tobacco use, major medical
illness, or sexual activity. There was no reported history of
laryngeal cancer or papillomatosis in his siblings, and no
abnormalpapsmearresultsorcervical lesionsinhismother.
Upon initial ofﬁce evaluation, the patient was notably
dysphonic. Oral examination revealed no visible or pal-
pable lesions of the ﬂoor of mouth, buccal mucosa, base of
the tongue, palate, or tonsillar fossae. On ﬂexible ﬁberoptic
laryngoscopic examination, there were no abnormalities
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Laryngeal evaluation, however, revealed an erythematous,
bulky lesion involving the entire length of the right true
vocal cord. Given these ﬁndings, the patient was scheduled
for a direct laryngoscopy and biopsy of the lesion in the
operating room with a presumed diagnosis of laryngeal
papilloma.
On further evaluation by direct laryngoscopy, the lesion
was found to be ﬁrmly attached to the right true vocal cord
although the right true vocal cord was freely mobile. The
right ventricle was obliterated due to its mass effect. The
lesion extended to the vocal process posteriorly, and near
to the anterior commissure anteriorly. Multiple biopsies
were obtained from the right vocal cord for histologic
diagnosis.
Materials and Methods
The hematoxylin–eosin stained slide prepared from a for-
malin-ﬁxed, parafﬁn-embedded tissue block was reviewed
by two board certiﬁed pathologists. Immunohistochemical
staining for p16 (p16INK4a kit; Dako, Carpinteria, CA) and
HPV types 6/11, 16/18, 31/33/51 (Zymo Research, Orange,
CA) were performed with appropriately reacting positive
and negative controls. In situ hybridization (ISH) was used
to detect HPV DNA types 6, 11, 16, 18, 31, 33, and 51, and
conﬁrmed by classical polymerase chain reaction (PCR).
PCR was performed with a platinum tag polymerase and a
set of degenerate primers (HPV-MY09, HPV-MY11, HPV-
GP5, and HPV-GP6) capable of binding DNAs of 23
mucosotrophic HPVs, including HPV-6, 11, 16, and 18.
Touchdown PCR was performed simultaneously and com-
pared with the results obtained by the classical PCR
method. For quality control, beta-globin was ampliﬁed
separately using a set of speciﬁc primers to ensure the
presence of sufﬁcient DNA for each PCR reaction. Dual-
color FISH assays were performed to evaluate chromosome
19p13.1 BRD4 and 15q13 NUT break points for the pres-
ence of t(15;19) as previously described [5].
Results
The right true vocal cord biopsy demonstrated in situ and
invasive moderately differentiated squamous cell carci-
noma (Fig. 1). It was concluded that the patient had a
T2N0Mx, stage II squamous cell carcinoma of the larynx.
Immunohistochemical staining for p16 showed strong and
diffuse nuclear and cytoplasmic staining in the tumor
(Fig. 2). Immunohistochemical staining for HPV 16/18
showed strong nuclear staining in numerous cells (Fig. 3).
ISH demonstrated co-expression of HPV DNA subtypes 16
Fig. 1 Histologic section of the right true vocal cord biopsy displays
squamous cell carcinoma (H & E 409)
Fig. 2 Immunohistochemical staining with p16 shows strong diffuse
nuclear and cytoplasmic staining in squamous cell carcinoma (109)
Fig. 3 Immunohistochemical staining with anti-papillomavirus anti-
body 16/18 reveals strong nuclear staining in numerous cells (109)
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assays failed to reveal translocation (15;19). After a mul-
tidisciplinary evaluation of the case, including radiation
oncology, medical oncology, and otolaryngology, the
decision was made to pursue radiation therapy to the true
vocal cords only, without chemotherapy or surgical
resection. The patient received hyperfractionated therapy
for 49 days with a total dose of 8160 cGy delivered.
Discussion
Squamous cell carcinoma of the larynx is extremely rare in
adolescents and children, and fewer than 75 cases have
been reported in the literature to date. Clinical manifesta-
tions of laryngeal carcinoma in adolescents may include
hoarseness or cough, which may be mistaken for common
respiratory infections, prepubertal voice change, or other
benign childhood conditions [9]. On laryngeal exam a
polyp or mass may be discovered, making juvenile papil-
lomatosis the presumed diagnosis. Due to its rarity,
tendency to mimic benign conditions, and the relative
difﬁculty of the pediatric laryngeal examination, SCC is
not usually considered in the differential diagnosis of
persistent hoarseness or cough, which may lead to a delay
in diagnosis.
Vocal folds are the most common site of involvement by
SCC in adolescents, followed by supraglottic and then
subglottic locations [9, 10]. In adolescents, 60% of cases
affect boys, compared to adults, in whom 80% of patients
are men [10, 11]. Additionally, cases increase in frequency
as patients increase in age [10, 11]. The major risk factor
for SCC in adolescents is prior radiation for juvenile pap-
illomatosis, in contrast to adults, in whom smoking is the
predominant etiological factor [9]. Other risk factors
include second-hand smoke, asbestos exposure, and a
family history of malignant tumors [12].
On biopsy, laryngeal squamous cell carcinoma in ado-
lescents closely parallels the squamous histology seen in
adult patients, although its behavior has been thought to be
more aggressive than that found in adults [11]. Laryngeal
carcinoma in adolescents has been reported to mirror that
of adults in regard to pattern of local spread [10].
The management of laryngeal malignancy in children is
more difﬁcult than in adults because the tumors tend to
behave more aggressively, likely due to their delayed
diagnosis [13]. Additionally, pediatric anatomic structures
are delicate, and there may be long-term complications
following treatment, including psychosocial factors spe-
ciﬁc to adolescents [13]. Treatment protocols have not been
well-established due to the scarcity of cases, but it is typ-
ically based upon the stage of the tumor, laryngeal cartilage
involvement, and metastases [13]. SCC in children tends to
respond to treatment in a way similar to that of SCC in
adults [10, 11]. Surgical resection may be difﬁcult in some
cases due to the desire to preserve laryngeal function and
voice. Initial management may combine surgery, radio-
therapy, and possibly chemotherapy.
In our case, the multidisciplinary team chose to treat the
patient with hyperfractionated radiation therapy only, with
a total dose of 8160 cGy delivered. After 1 year of follow-
up, our patient is doing well and had complete eradication
of his SCC without recurrence. However, long-term fol-
low-up will be important for our patient, as well as other
patients, who are at an increased risk for radiation-induced
endocrinologic deﬁciencies, arrested growth of irradiated
tissues, and for the development of second malignancies.
The prognosis of laryngeal carcinoma in adolescents is
unclear because survival rates have not been reported
according to tumor stage due to the scarcity of cases [14].
Recently, studies have suggested that prognosis may be
affected by the presence of chromosomal translocation
(15;19) or the presence of HPV DNA within the tumor
cells. Translocation (15;19) results in a BRD4-NUT fusion
oncogene, which likely disrupts the normal BRD4 function
of regulation of cell cycle progression [6]. Translocation
(15;19) has been described as part of a distinct clinico-
pathologic entity characterized by young age, female
predilection, midline carcinoma of the neck or upper tho-
rax, and a rapidly fatal course [1]. The limited literature on
translocation (15;19) carcinoma suggests that this entity
arises from thymic or respiratory epithelium and is very
unresponsive to aggressive chemoradiotherapy and is
commonly lethal [5]. Rahbar et al. reported in [2] the
presence of translocation (15;19) in carcinoma of the upper
aerodigestive tract in children indicates a poor prognosis
despite aggressive multi-modality treatment . The two
children in this study with translocation (15;19) both died
of their disease with a mean survival of 6 months, com-
pared to the ﬁve children without translocation (15;19) who
were disease free at a mean follow-up of 47 months.
French et al. [5] found in 2004 that of 11 patients with
translocation (15;19), 43% had poorly differentiated car-
cinomas and 47% arose within the respiratory tract . Our
case was evaluated by dual-color FISH assays and found to
be negative for translocation (15;19).
It has been well-established that low risk HPV DNA is
an etiological factor in the development of laryngeal pap-
illomas. Major et al. [15] found that low risk HPV-6 and
HPV-11 DNA were present in 100% of recurrent respira-
tory papillomatosis cases. Additionally, HPV-11 was found
in all laryngeal and bronchogenic cancers in patients with a
history of early onset RRP [16]. Many cancers of the head
and neck have also been reported to express HPV DNA,
however, the results of the studies are quite variable, pos-
sibly due to the small number of cases, the different HPV
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DNA subtypes included in the detection method. The lit-
erature reveals the broad heterogeneity in the results of
these studies with a wide range of reported HPV positivity
in head and neck cancers and, more speciﬁcally, laryngeal
carcinoma.
On average, most studies investigating HPV in head in
neck SCC reﬂect a HPV positivity rate close to 35%. In
2005, a meta-analysis of 5046 head and neck SCC speci-
mens from 60 studies found an overall HPV positivity of
25.9% [17]. Gallegos-Hernandez et al. found HPV posi-
tivity in 42% (118 patients) of head and neck SCC, while
Badaracco et al. identiﬁed HPV in 18.3% of 115 patients
with head and neck SCC [7, 18]. A report published in [19],
studied 253 cases of oropharyngeal carcinoma and identi-
ﬁed HPV DNA in 25% of the samples. Syrangen et al. [3]
found tonsillar carcinomas to have a higher prevalence of
HPV at 51%, compared to 22% of oral carcinomas and
sinonasal carcinomas.
With regard to SCC of the larynx, the frequency of HPV
positivity is quite variable. A meta-analysis in 2005
included 1435 cases of laryngeal cancer, which demon-
strated HPV DNA positivity in 24% [17]. In [20], it was
reported that HPV DNA was detected in 37.3% of the 110
cases of laryngeal carcinoma that were studied by de
Oliveria et al. Gallegos-Hernandez et al. found HPV pos-
itivity in 50% of laryngeal cancer patients, whereas the
HPV prevalence was 13% in a study of 91 laryngeal car-
cinomas by Gorgoulis et al. [18, 21].
Many studies have investigated the frequency with
which the most common North American HPV subtypes
are present in head and neck SCC. Most reports are in
agreement that HPV-16 is the most frequently isolated
subtype. Gallegos-Hernandez et al. [18] reported HPV-16
in 68.7% of 118 HPV-positive cases of head and neck SCC.
Badaracco et al. [7] also found HPV-16 to be the most
frequent subtype in 67% of 21 HPV-positive cases of head
and neck SCC, followed by HPV-6, HPV-33, HPV-35, and
HPV-58. HPV-16 was reported in 90% of the HPV-positive
oropharyngeal carcinomas by Gillison et al. [19]. In 2005,
Syrangen found HPV-16 in 84% of tonsillar tumors [3].
Balukova et al. studied 48 patients with laryngeal cancer
and detected HPV-18 in 13%, while Gorgoulis et al. found
HPV-16 to be present in 63% of 19 cases of laryngeal
carcinoma [21, 22].
In our case report, the tumor was strongly positive for
p16, as well as for the expression of HPV DNA types 16 and
18 by immunohistochemistry, ISH and PCR. In 1994, a
12 year-old boy had laryngeal SCC that co-expressed HPV
DNA types 18 and 33 [23]. The boy had no other risk factors
for SCC and the authors concluded that coinfection by two
HPV types might substitute for carcinogenic cofactors
normally present in adult laryngeal carcinomas. In 2006,
two cases of laryngeal cancer were found to contain both
high-risk and low-risk HPV by Manjarrez et al., [24] sug-
gesting that both low-risk and high-risk HPV might be
involved in the development of laryngeal malignant tumors,
and that these viruses may be a synergistic risk factor for
malignant development. Gorgoulis et al. [21] found HPV
co-expression in 3 of 19 HPV-positive cases with HPV
types 6/33, 16/33, and 6/18. Given that HPV can be iden-
tiﬁed in up to 25% of normal laryngeal mucosa samples, it
could also be hypothesized that the low-risk infection may
only be incidental and that the carcinogenic effect is a
solitary effort by the high-risk HPV subtype [21, 25].
Although many studies have investigated the presence
of HPV in head and neck cancers, only a few have corre-
lated its prognostic signiﬁcance. It has been reported that
HPV-positive cancers of the head and neck, including the
tonsil, oropharynx and oral cavity have a better overall
survival than HPV-negative cancers [3, 4, 7, 8]. Two
studies found that male gender contributed to a greater
prognosis in patients with HPV-positive cancers [3, 4].
Cancers commonly contain alterations involving the p16
gene. The p16(INK4a) protein inhibits cyclin-dependent
kinases and acts as a tumor suppressor to negatively
regulate the cell cycle [26]. Evidence suggests that over-
expression of the p16(INK4a) protein indicates infection
with and genomic integration of high-risk HPV [27].
Additionally, it and predicts progression to cervical high-
grade squamous intraepithelial lesions (HSILs) and carci-
noma due to HPV-induced cell cycle dysregulation [27].
Therefore, p16 immunostaining of tumor nuclei and cyto-
plasm may serve as a marker for HPV positivity of the
tumor.
Because the p16 protein is an important cell cycle reg-
ulatory protein, underexpression of this protein will allow
cancer cells to proliferate without control. In HPV-negative
lesions, downregulation of p16 has been correlated with
increased dedifferentiation, more locally advanced stage,
and tendency for radiotherapy failure in laryngeal SCC [28,
29]. Yuen et al. [29] found decreased p16 expression in
48% of the 225 head and neck squamous cell carcinomas
studied in 2002. Additionally, the same study reported
tumors of the larynx to have a signiﬁcantly higher fre-
quency of weak p16 expression compared with tumors of
the oral cavity and pharynx.
As evidenced by our case report, laryngeal SCC in
adolescents may present with nonspeciﬁc symptoms that
mimic benign childhood conditions and lead to a delayed
diagnosis. Early recognition and diagnosis is of therapeutic
importance because of its aggressive nature, potential for
associated complications and frequently poor outcome.
This case report demonstrates that HPV can be positive in
laryngeal SCC in adolescents, therefore, HPV testing
should be considered for all laryngeal SCC in adolescents
40 Head and Neck Pathol (2009) 3:37–41since it has both prognostic and potentially therapeutic
implications. In addition, given this HPV expression,
vaccination may be considered and requires further
investigation.
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